1. Home
  2. VRTX vs HOOD Comparison

VRTX vs HOOD Comparison

Compare VRTX & HOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

HOLD

Current Price

$459.29

Market Cap

115.7B

Sector

Technology

ML Signal

HOLD

Logo Robinhood Markets Inc.

HOOD

Robinhood Markets Inc.

HOLD

Current Price

$117.90

Market Cap

105.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRTX
HOOD
Founded
1989
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Computer Software: Prepackaged Software
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
115.7B
105.6B
IPO Year
1991
2021

Fundamental Metrics

Financial Performance
Metric
VRTX
HOOD
Price
$459.29
$117.90
Analyst Decision
Buy
Buy
Analyst Count
27
24
Target Price
$501.42
$120.59
AVG Volume (30 Days)
1.3M
21.8M
Earning Date
02-09-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
304.26
EPS
14.22
2.39
Revenue
$11,723,300,000.00
$4,204,000,000.00
Revenue This Year
$11.01
$54.96
Revenue Next Year
$8.74
$23.18
P/E Ratio
$32.61
$48.21
Revenue Growth
10.33
74.58
52 Week Low
$362.50
$29.66
52 Week High
$519.68
$153.86

Technical Indicators

Market Signals
Indicator
VRTX
HOOD
Relative Strength Index (RSI) 52.78 46.97
Support Level $443.12 $113.87
Resistance Level $487.52 $124.35
Average True Range (ATR) 9.35 3.97
MACD -0.29 0.12
Stochastic Oscillator 36.42 52.93

Price Performance

Historical Comparison
VRTX
HOOD

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About HOOD Robinhood Markets Inc.

Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.

Share on Social Networks: